Single-use Bioprocessing Market Size, Share, and Trends 2024 to 2034

The global single-use bioprocessing market size was estimated at USD 25.44 billion in 2022 and is expected to hit USD 84.12 billion by 2030, poised to grow at a noteworthy CAGR of 16.1% from 2023 to 2030. U.S. single-use bioprocessing market was accounted at USD 6.7 billion in 2022.

Key Takeaway:

• North America has captured revenue share of 34.5% in 2022.
• Asia Pacific region is anticipated to grow at CAGR of 16.5% over the forecast period 2023 to 2030.
• By Product, the simple & peripheral elements segment has accounted 49.4% revenue share in 2022.
• By Workflow, the upstream bioprocessing segment recorded revenue share of 57.8% in 2022.
• By End-use, the biopharmaceutical manufacturers segment has held larghest revenue share of around 58.5% in 2022.
• Academic & clinical research institutes segfment are expected to reach at a 16.37% of CAGR from 2023-2030.

Growth Factors

The single-use bioprocessing market is significantly driven by the growing demand from the biopharmaceutical industry. Majority of the biopharmaceutical companies are increasingly adopting the single-use bioprocessing technology because the single-use bioprocessing systems increases the efficiency in the process and reduces the costs associated with sterilization, cleaning, and maintenance of steel bioreactors. In biopharmaceutical, the single-use bioprocessing system is used in a wide range of applications such as storage, filtration, purification, and mixing. Moreover, the biopharmaceuticals is rapidly growing. The biopharmaceutical alone forms around 20% of the global pharma market. The extensive use of biopharmaceuticals as therapeutic agents like cell therapies, allergenic agents, and vaccines to name a few. It is also used in the treatment of cancer. Hence, the rapid growth of biopharmaceuticals is significantly boosting the demand for the single-use bioprocessing system.

The growing geriatric population across the globe is expected to fuel the market growth in the upcoming years. According to the United Nations, by 2050, it is estimated that around 1.5 billion of the global population will be of 65 years or above. The geriatric population are more prone to chronic diseases and hence the demand and consumption of biopharmaceutical medicines will rise extensively, thereby propelling the growth of the global single-use bioprocessing market.

Single-Use Bioprocessing Market Scope

Product Insights

By product, the media bags and containers segment led the global single-use bioprocessing market with remarkable revenue share in 2022 and is anticipated to retain its dominance throughout the forecast period. The use of media bags and containers offers low investment, lower wastes emission, and lower operational costs in the biopharmaceutical industry. Moreover, the single-use media bags and containers offers temperature resistance along with durability. Therefore, the extensive use of media bags and containers in the biopharmaceuticals have augmented the segment growth in the recent years.

End User Insights

By end user, the biopharmaceutical manufacturers segment led the market in 2022 and the rapid growth of biopharmaceuticals industry is significantly boosting the growth of this segment. Moreover, more than 80% of the biopharmaceutical plants have adopted the single-use bioprocessing systems as this is cheaper, efficient, and reliable.

The extensive and increasing use of single-use or disposables by the contract manufacturers have augmented the segment growth. Furthermore, the increased demand for the single-use bioprocessing systems in various bioprocessing services is expected to foster the market growth in the foreseeable future.

Application Insights

By application, the filtration segment led the global single-use bioprocessing market with remarkable revenue share in 2022 and is anticipated to retain its dominance throughout the forecast period. This is attributed to the increasing adoption of single-use bioprocessing system in filtration owing to its efficient filtration even at large scale. It is used for bioburden reduction, polishing of biomolecules, and for ultrafiltration.

Regional Insights

Based on the region, the North America dominated the market in 2022 and is estimated to be the most opportunistic market. This is attributed to the rapid growth and development of biopharmaceutical industry in the region. Moreover, the outbreak of the COVID-19 pandemic stimulated the government to invest heavily in the research and development of the COVID-19 vaccines, diagnostics tests, and drugs. The US government sanctioned over US$ 480 million to Moderna, Inc., for the development of COVID-19 vaccines. The Canada government spent around US$ 160 million in 2020, towards the development of vaccines and drugs for COVID-19 treatment.

The presence of giant players, largescale production units, growing adoption of disposables, increased expenditure in health care, and highly developed healthcare infrastructure are the top factors augmenting the North America single-use bioprocessing market. Moreover, the numerous contract manufacturers and the growing usage of disposables amongst them is exponentially driving the single-use bioprocessing market in the region.

The Asia Pacific has potential growth opportunities owing to the growing biopharmaceutical market in the nations such as China, Japan, and India. Moreover, rising investments by the biotechnology and pharmaceutical companies and the rapid growth of the contract manufacturers may lead to the emergence of Asia Pacific to be the manufacturing hub for the pharmaceuticals. Hence, the region may contribute significantly towards the growth of the single-use bioprocessing market in the forthcoming years.

Key Companies & Market Share Insights

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improvedand efficient solutions. Moreover, they are also focusing on maintaining competitive pricing.

In February 2020, MabPlex, a contract manufacturing company, launched two new cell culture production lines with 2000-liter disposable bioreactors. The various developmental strategies undertaken by key market players increases competition and contributes significantly towards the development of single-use bioprocessing market.

Single-Use Bioprocessing Market Companies

• Thermo Fisher Scientific, Inc.
• Sartorius AG
• Merck KGaA
• Pall Corporation
• Corning Incorporated
• Eppendorf AG
• General Electric Company (GE Healthcare)
• Lonza
• Rentschler Biopharma SE
• JM BioConnect
• Meissner Filtration Products, Inc.
• Infors AG
• BoehringerIngelheim GmbH
• Entegris, Inc.
• PBS Biotech, Inc.

Segments Covered in the Report

By Product

• Filtration Assemblies
• Disposable Bioreactors
• Disposable Mixers
• Media Bags & Containers
• Others

By Application

• Filtration
• Purification
• Cell Culture
• Others

By End User

• Biopharmaceutical Manufacturers
• Clinical & Academic Research Institutes
• Others

By Workflow

• Upstream
• Fermentation
• Downstream

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Rest of the World